NCT05764642
A Study of Renal Microvessel Imaging for Chronic Kidney Disease
Enrolling by Invitation
PHASE2Ages 18+InterventionalDiagnosticMayo ClinicInvestigator-initiated
~186 participants
Updated 2025-09-05 on ClinicalTrials.gov
What's tested:DefinitySuper-resolution ultrasound imaging
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Renal cortex microvessel density
Measured over Baseline
+2 more outcomes measured
Conditions
Where it's being run
2 sites across 2 statesFlorida1
Minnesota1
Study leadership
- Shigao Chen, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
Subjects lacking capacity to consent.
Vulnerable subjects such as prisoners; pregnant women; nursing mother.
Subjects with history of hypersensitivity allergic reactions to ultrasound contrast agents.
Patients with high-risk cardiac diseases.
What this trial measures
- Renal cortex microvessel densityBaseline
Super-Resolution Ultrasound Imaging (SRUI) parameters reported in percentage
- Renal cortex microvessel diameterBaseline
Super-Resolution Ultrasound Imaging (SRUI) parameters reported in millimeters (mm)
- Renal blood flow velocityBaseline
Super-Resolution Ultrasound Imaging (SRUI) parameters reported in centimeters per second (cm/sec)